Asset Dedication’s NanoViricides NNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.88K Hold
1,450
– – ﹤0.01% 1025
2026
Q2
$2K Hold
1,450
– – ﹤0.01% 1038
2026
Q1
$1.32K Hold
1,450
– – ﹤0.01% 999
2025
Q4
$1.64K Hold
1,450
– – ﹤0.01% 1019
2025
Q3
$2.07K Hold
1,450
– – ﹤0.01% 1017
2025
Q2
$2.03K Hold
1,450
– – ﹤0.01% 1031
2025
Q1
$1.7K Hold
1,450
– – ﹤0.01% 979
2024
Q4
$2.07K Hold
1,450
– – ﹤0.01% 968
2024
Q3
$2.18K Hold
1,450
– – ﹤0.01% 1001
2024
Q2
$2.49K Hold
1,450
– – ﹤0.01% 1040
2024
Q1
$2K Hold
1,450
– – ﹤0.01% 896
2023
Q4
$1K Hold
1,450
– – ﹤0.01% 946
2023
Q3
$2K Hold
1,450
– – ﹤0.01% 902
2023
Q2
$2K Hold
1,450
– – ﹤0.01% 872
2023
Q1
$2K Hold
1,450
– – ﹤0.01% 859
2022
Q4
$2K Hold
1,450
– – ﹤0.01% 875
2022
Q3
$3K Buy
+1,450
New +$3.16K ﹤0.01% 789

Other funds holding NNVC

Asset Dedication's NNVC Position: Q3 2026 in Review

Asset Dedication held its NanoViricides (NNVC) position steady in Q3 2026 at 1,450 shares worth $1.88K. The position accounts for ﹤0.01% of the portfolio, ranked #1025.

Asset Dedication first reported a position in NNVC in Q3 2022 and has held it in 17 quarters since. The position peaked at $3K in Q3 2022. 38 funds tracked by Wall St. Rank hold NNVC as of Q3 2026.

  • Asset Dedication held 1,450 shares of NanoViricides worth $1.88K as of Q3 2026.
  • Asset Dedication left its NanoViricides share count unchanged in Q3 2026.
  • NanoViricides made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #1025 holding.
  • Asset Dedication first reported a position in NanoViricides in Q3 2022 and has held it in 17 quarters since.
  • Asset Dedication's NanoViricides position peaked at $3K in Q3 2022.
  • 38 funds tracked by Wall St. Rank held NanoViricides as of Q3 2026.

Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.